Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2025)

Caris Life Sciences has reported Other Non Operating Income over the past 2 years, most recently at -$2.1 million for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$2.1 million for Q4 2025, down 8026.92% from a year ago — trailing twelve months through Dec 2025 was -$20.6 million (changed N/A YoY), and the annual figure for FY2025 was -$20.6 million, down 5791.12%.
  • Other Non Operating Income for Q4 2025 was -$2.1 million at Caris Life Sciences, down from -$89000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for CAI hit a ceiling of $37000.0 in Q3 2024 and a floor of -$18.3 million in Q2 2025.